XML 146 R136.htm IDEA: XBRL DOCUMENT v3.25.4
Parent Company Only Financial Statements - Condensed Statements of Cash Flows (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Condensed Financial Statements, Captions [Line Items]      
Net Income (Loss) $ 91,749,000 $ 78,898,000 $ 68,935,000
Depreciation, amortization and accretion, net 19,771,000 20,778,000 14,904,000
Increase in other assets 10,566,000 33,524,000 (20,562,000)
Increase (decrease) in other liabilities 3,534,000 (4,191,000) (1,674,000)
Net cash provided by operating activities 130,874,000 124,425,000 72,417,000
Net cash (used in) provided by investing activities (302,625,000) (7,509,000) 474,380,000
Repayment of short-term debt (4,000,000) 0 0
Proceeds from short-term debt 4,000,000 0 0
Proceeds from issuance of common stock 1,120,000 1,054,000 1,004,000
Payment to repurchase common stock (724,000) (659,000) (465,000)
Dividends paid on common stock (23,395,000) (22,371,000) (19,557,000)
Net cash (used in) provided by financing activities 305,455,000 (138,764,000) (556,166,000)
Increase (decrease) in cash and cash equivalents 133,704,000 (21,848,000) (9,369,000)
Cash and cash equivalents at beginning of period 121,216,000 143,064,000 152,433,000
Cash and cash equivalents at end of period 254,920,000 121,216,000 143,064,000
Parent Company [Member]      
Condensed Financial Statements, Captions [Line Items]      
Net Income (Loss) 91,749,000 78,898,000 68,935,000
Depreciation, amortization and accretion, net 0 0 265,000
Dividends received from subsidiary 0 0 51,213,000
Equity in undistributed earnings of subsidiaries (20,715,000) (28,581,000) (26,374,000)
Increase in other assets (12,522,000) (2,221,000) (49,606,000)
Increase (decrease) in other liabilities 4,798,000 (871,000) 1,526,000
Net cash provided by operating activities 63,310,000 47,225,000 45,959,000
Investment in subsidiary 0 (4,000,000) 0
Net cash from (used in) business acquisition 0 0 (41,827,000)
Other 3,654,000 0 0
Net cash (used in) provided by investing activities 3,654,000 (4,000,000) (41,827,000)
Repayment of long-term debt (29,882,000) (19,455,000) 0
Proceeds from issuance of common stock 1,120,000 1,054,000 1,004,000
Payment to repurchase common stock (724,000) (659,000) (465,000)
Dividends paid on common stock (23,395,000) (22,371,000) (19,557,000)
Net cash (used in) provided by financing activities (52,881,000) (41,431,000) (19,018,000)
Increase (decrease) in cash and cash equivalents 14,083,000 1,794,000 (14,886,000)
Cash and cash equivalents at beginning of period 11,762,000 9,968,000 24,854,000
Cash and cash equivalents at end of period $ 25,845,000 $ 11,762,000 $ 9,968,000